Something different- brodalumab and ixekizumab

http://www.ncbi.nlm.nih.gov/pubmed/23013312

These just finished phase II, and they plan on seeking approval for plaque psoriasis first so it'll be some time. Has anyone heard about these meds?

They are dubbed Stelara 2.0. They seem to be great for plaque psoriasis, but I wasn’t to impressed with PsA data provided. However, it’s too early to determine how well they will be for PsA.